Migraine clinical trials in Florida
13 studies for Migraine are looking for participants at sites in Florida.
Cities in Florida
Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
- Memorial Healthcare, Hollywood
- Mayo Clinic Florida, Jacksonville
- Apple Med Research, Miami
- and 1 more
RecruitingPhase 4
Ages 18 to 70 · All sexes · Updated Nov 13, 2026 · NCT06972056Study of EVO756 in Adults With Migraine
- Apple Medical Research Group, Inc, Miami
- Blessed Healthcase & Research, Miami
- Florida Research Center, Inc., Miami
- and 3 more
RecruitingPhase 2
Ages 18 to 64 · All sexes · Updated Nov 13, 2026 · NCT07616128A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- Velocity Clinical Research, Hallandale Beach, Hallandale
- Clinical Research of Central Florida, Lakeland
- AppleMedical Research Group, LLC, Miami
- and 4 more
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Nov 12, 2026 · NCT07816367A Prospective, Open-Label Study Evaluating the Effectiveness of Gepants for Acute Treatment of Migraine in the Emergency Department
- Tampa General Hospital Emergency Room, Tampa
RecruitingPhase 1Healthy volunteers welcome
Ages 18 and older · All sexes · Updated Oct 27, 2026 · NCT07667621Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
- South Florida Research Phase I-IV, Inc, Miami
- Clinical Associates of Orlando, LLC, Orlando
RecruitingPhase 3
Ages 6 to 17 · All sexes · Updated Oct 27, 2026 · NCT04743141Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- South Florida Research Phase I-IV, Inc, Miami
- Aqualane Clinical Research, Naples
- Clinical Associates of Orlando, LLC, Orlando
RecruitingPhase 3
Ages 6 to 17 · All sexes · Updated Oct 27, 2026 · NCT04649242Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
- Direct Helpers Research Center, Hialeah
- D&H Tamarac Research Center LLC, Tamarac
- Santos Research Center, CORP, Tampa
RecruitingPhase 3
Ages 6 to 17 · All sexes · Updated Oct 14, 2026 · NCT05156398A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine
- NW FL Clinical Research Group, LLC, Gulf Breeze
- AGA Clinical Trials, Hialeah
- University of South Florida (USF) - Tampa Campus, Tampa
RecruitingPhase 3
Ages 6 to 17 · All sexes · Updated Oct 14, 2026 · NCT05164172A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
- Northwest Florida Clinical Research Group, LLC /ID# 270833, Gulf Breeze
- My Preferred Research /ID# 270312, Miami
- Encore Medical Research - Weston /ID# 271139, Weston
- and 1 more
RecruitingPhase 3
Ages 12 to 17 · All sexes · Updated Oct 9, 2026 · NCT06810505Study Evaluating the Efficacy, Safety, and Tolerability of ASY202 (Dihydroergotamine Mesylate [DHE] Inhalation Powder Delivered Via a Multidose Dry Powder Inhaler) for the Acute Treatment of Migraine in Adult Patients
- Clinical Neuroscineces Solutions - Orlando, Orlando
- Clinical Neuroscineces Solutions, Orlando
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Oct 9, 2026 · NCT07646613Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- Encore Medical Research of Boynton Beach LLC /ID# 246833, Boynton Beach
- Gulf Coast Clinical Research Center /ID# 230020, Fort Myers
- AGA Clinical Trials /ID# 230554, Hialeah
- and 9 more
RecruitingPhase 3
Ages 6 to 17 · All sexes · Updated Sep 14, 2026 · NCT05125302Real-world Prospective Study on the Use of Anti-CGRP Drugs in Migraine
- University of Miami, Miller School of Medicine, Miami
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 8, 2025 · NCT07159750Qudexy XR for the Prevention of Migraine in Children 6 to 11 Years Old
- Upsher-Smith Clinical Trial Site #14, Tampa
RecruitingPhase 4
Ages 6 to 11 · All sexes · Updated Jan 27, 2025 · NCT04748601From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.